Humana (HUM) Form 4 — 609 RSUs Vest, 240 Shares Disposed at $253.12
Rhea-AI Filing Summary
George Renaudin II, an officer of Humana Inc. (HUM), reported changes in his beneficial ownership on transactions dated 10/01/2025. The filing shows 609 restricted stock units vested/added (transaction code M) and a disposition of 240 shares sold at $253.12, leaving him with 16,071 shares directly beneficially owned after the sale.
The Form 4 also discloses outstanding equity awards: stock options covering 4,162 shares with a conversion/exercise price of $510.2425 (exercisable 02/24/2030) and 6,966 shares with a $367.21 exercise price (exercisable 02/21/2031). The filing notes 11,165 restricted stock units included in the total and 172 phantom stock units held indirectly under the company plans.
Positive
- 609 restricted stock units vested on 10/01/2025, demonstrating compensation plan payouts
- Officer retains substantial long-term equity: 4,162 and 6,966 option shares outstanding with multi-year exercisability
Negative
- 240 shares were disposed of at $253.12 on 10/01/2025, representing an immediate reduction in direct holdings
- Outstanding option strike prices include $510.2425, which is above the disclosed sale price of $253.12
Insights
Officer reported routine vesting and a small disposition; no unusual insider activity.
The Form 4 shows a 609-unit restricted stock vesting event on 10/01/2025 and a contemporaneous sale of 240 shares at $253.12 to cover tax liabilities per the footnotes. These are common, Rule 16b-3-exempt compensation plan events disclosed by officers rather than market-timing trades.
The filing records both direct and indirect holdings, including retirement-plan and phantom-unit balances, clarifying the officer's long-term alignment with shareholders.
Significant outstanding option grants remain unexercised with multi-year vesting horizons.
The officer holds options for 4,162 shares at $510.2425 (exercisable 02/24/2030) and 6,966 shares at $367.21 (exercisable 02/21/2031), indicating multi-year incentive structures from grants dated 02/24/2023 and 02/21/2024 respectively as noted in the footnotes. The vesting schedule and presence of phantom and retirement-plan units show a mix of near-term and long-term compensation vehicles.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 609 | $0.00 | -- |
| Exercise | Humana Common | 609 | $0.00 | -- |
| Tax Withholding | Humana Common | 240 | $253.12 | $61K |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Phantom Stock Units | -- | -- | -- |
| holding | Humana Common | -- | -- | -- |
Footnotes (1)
- Shares held for the benefit of reporting person as of September 30, 2025 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c). Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). Restricted stock units granted to reporting person on 10/1/2022, 100% of the award is vesting on 10/1/2025. Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Includes 11,165 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Phantom Stock Units held for the benefit of reporting person as of September 30, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price. Shares disposed of represent payment for tax liability on restricted stock vesting on 10/1/25. No value was received in return.
